文献速递神经肿瘤

颅骨弥漫性Paget病:骨显像中锝-99m双膦酸盐示踪剂浓聚

Diffuse Paget's Disease of the Skull with Intense Uptake of Technetium-99m-Labeled Diphosphonate Tracer in Bone Scintigraphy.
PubMed 文献 · World Neurosurg · 2021-04-30

本文报告一例既往诊断为垂体腺瘤和轻度颅骨Paget病的患者,骨显像(核医学成像)显示锝-99m标记双膦酸盐示踪剂在颅骨呈弥漫性特征性摄取。病例强调核医学成像能快速显示和评估Paget病受累的进展性分布。

要点

  • 骨显像可快速显示Paget病颅骨弥漫性受累及进展分布。
  • 对已诊断Paget病者,核医学成像有助评估病变范围与进展。
  • 影像学(X线、CT、MRI、核医学)对Paget病临床评估均重要。

核心结论

  • 核医学成像能快速显示和评估Paget病受累的进展性分布。

研究设计与样本

  • 个案报道:一例既往诊断垂体腺瘤和轻度颅骨Paget病的患者。

主要发现

  • 骨显像显示锝-99m标记双膦酸盐示踪剂在颅骨呈弥漫性特征性摄取。

临床怎么用

  • 对Paget病患者可用核医学成像快速评估颅骨病变分布及进展。

局限性

  • 为单个病例报道,不能推断诊断准确性或人群普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Imaging in patients with Paget's disease of bone is very important clinically to show the presence of Pagetic abnormalities, assess disease progression, and identify adversely affected structures throughout disease course. Abnormalities and progression may be seen on radiographs, computed tomography, magnetic resonance imaging, and nuclear imaging. Herein, we report a case Paget's disease of bone showing diffuse characteristic pathology using technetium-99m-labelled diphosphonate tracer in bone scintigraphy (nuclear imaging). This case emphasizes the ability of nuclear imaging to rapidly visualize and assess progressive distribution of Pagetic involvement in a patient previously diagnosed with pituitary adenoma and mild Paget's disease of the skull.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Griepp DW, Sajan A, Sighary M, et al. Diffuse Paget's Disease of the Skull with Intense Uptake of Technetium-99m-Labeled Diphosphonate Tracer in Bone Scintigraphy. World Neurosurg. 2021. PMID: 33940269. doi:10.1016/j.wneu.2021.04.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。